Edition:
United Kingdom

Aviragen Therapeutics Inc (AVIR.OQ)

AVIR.OQ on NASDAQ Stock Exchange Capital Market

0.59USD
4:05pm GMT
Change (% chg)

$-0.00 (-0.68%)
Prev Close
$0.59
Open
$0.60
Day's High
$0.60
Day's Low
$0.59
Volume
8,589
Avg. Vol
98,633
52-wk High
$1.48
52-wk Low
$0.44

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.10 -0.153
Mar '17 4.90 -0.114
Dec 3.80 -0.235
Sep 0.10 -0.259
FY 2016 Jun '16 0.50 -0.181
Mar '16 5.30 -0.135
Dec 1.70 -0.168
Sep 1.70 -0.171
FY 2015 Jun '15 4.10 -0.551
Mar '15 5.90 0.034
Dec 13.90 0.185
Sep 0.70 -0.197
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-17 3 0.67 1.00 0.50 --
Year Ending Jun-17 3 8.43 9.80 6.20 --
Earnings (per share)
Quarter Ending Jun-17 2 -0.20 -0.17 -0.23 --
Year Ending Jun-17 2 -0.81 -0.78 -0.83 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.65 32.93
P/E High - Last 5 Yrs. -- 290.75 45.62
P/E Low - Last 5 Yrs. -- 93.66 24.34
Beta 0.02 0.85 0.88
Price to Sales (TTM) 3.04 100.67 5.40
Price to Book (MRQ) 1.45 13.50 5.38
Price to Tangible Book (MRQ) 1.45 13.43 6.78
Price to Cash Flow (TTM) -- 76.23 23.45
% Owned Institutions 37.92 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -80.00 433.84 9.00
Sales (TTM) vs TTM 1 Yr. Ago -3.26 75.03 5.38
Sales - 5 Yr. Growth Rate -- 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 15.73 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -16.18 -- --
EPS - 5 Yr. Growth Rate -- 43.17 10.79
Capital Spending - 5 Yr. Growth Rate -- 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 6.76 5.36 2.98
LT Debt to Equity (MRQ) 0.53 18.92 11.56
Total Debt to Equity (MRQ) 1.60 20.59 15.81
Interest Coverage (TTM) -62.25 -112.49 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -305.62 -- --
EBITD - 5 Yr. Avg -- -261.11 15.24
Operating Margin (TTM) -310.11 -556.64 7.76
Operating Margin - 5 Yr. Avg. -- -279.29 10.75
Pre-Tax Margin (TTM) -326.97 -529.88 8.57
Pre-Tax Margin - 5 Yr. Avg. -- -279.02 11.17
Net Profit Margin (TTM) -330.34 -531.33 4.88
Net Profit Margin - 5 Yr. Avg. -- -282.20 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 25,314,503 864,673,366
Net Income/Employee (TTM) -- 3,332,048 101,717,513
Receivable Turnover (TTM) 13.69 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.16 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -52.13 -0.78 11.00
Return on Assets - 5 Yr. Avg. -- -0.26 12.43
Return on Investment (TTM) -60.18 2.35 14.46
Return on Investment - 5 Yr. Avg. -- 2.98 16.28
Return on Equity (TTM) -90.60 2.95 16.05
Return on Equity - 5 Yr. Avg. -- 6.40 17.51
  1 Year 3 Year 5 Year
Sales % -4.30 -49.40 --
EPS (TTM) % -15.72 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aviragen Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 40.25%
# of Holders: 40
Total Shares Held: 15,556,536
3 Mo. Net Change: 895,892
# New Positions: 4
# Closed Positions: 4
# Increased Positions: 11
# Reduced Positions: 8
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.